The content creator, 26, was diagnosed with a rare bile duct cancer nearly three years ago ...

Former hockey heartthrob Ron Duguay — who’s now former veep candidate Sarah Palin’s romantic running mate — has revealed he ...

Findings from a phase 1/2 trial (NCT04176) presented at the 2025 American Society of Hematology Annual Meeting and Exposition ...

A large analysis from the Global Burden of Disease collaborators projects that annual female breast cancer cases could climb from roughly 2.3 million in 2023 to about 3.56 million by 2050, with deaths ...

AstraZeneca and Daiichi Sankyo's supplemental Biologics License Application (sBLA) for Enhertu (trastuzumab deruxtecan) has been accepted and granted ...

Nurses and advanced practice registered nurses (APRNs) play a central role in preventive care, screening, chronic disease management, and patient education. Expanding this workforce is particularly ...

Jen Holifield has multiple myeloma, an incurable blood cancer. Her doctor prescribed Lenalidomide — brand name Revlimid — to treat it. She has not been able to fill that prescription in more than two ...

We’re throwing our support behind 35-year-old Jessica, who is currently undergoing chemotherapy for a Grade 3 ovarian cancer that is very rare and unpredictable—specifically, a mucinous adenocarcinoma ...

Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR rate at 12 months and 94% CR rate at any time ...

The return to work was filled with emotion for Carlo Vanzini, the historic voice of Formula 1 in Italy. After difficult ...

Lawmakers in Richmond can help patients by enacting policies that alleviate this financial burden, and I share the goal ...

Stockholm, March 9, 2026 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company specializing in difficult-to-treat cancers, today announces that it has achieved key regulatory agreement ...